These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemoembolization and bland embolization: a critical appraisal. Befeler AS Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274 [TBL] [Abstract][Full Text] [Related]
8. Liver-directed treatment modalities for primary and secondary hepatic tumors. Yamane B; Weber S Surg Clin North Am; 2009 Feb; 89(1):97-113, ix. PubMed ID: 19186233 [TBL] [Abstract][Full Text] [Related]
9. Opportunities for targeted therapies in hepatocellular carcinoma. Thomas MB; Abbruzzese JL J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107 [TBL] [Abstract][Full Text] [Related]
10. Management of hepatocellular carcinoma. Lau WY J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260 [TBL] [Abstract][Full Text] [Related]
11. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Zhu AX Oncologist; 2006; 11(7):790-800. PubMed ID: 16880238 [TBL] [Abstract][Full Text] [Related]
12. Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach. Bathaix F; Marion D; Cuinet M; Maillard E; Zoulim F; Mornex F; Merle P Gastroenterol Clin Biol; 2010; 34(4-5):314-8. PubMed ID: 20207091 [TBL] [Abstract][Full Text] [Related]
13. Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies. Lencioni R Oncology; 2010 Jul; 78 Suppl 1():107-12. PubMed ID: 20616592 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status. Paul SB; Guglani B; Gulati MS; Batra Y; Mukhopadhyay S Trop Gastroenterol; 2003; 24(4):176-84. PubMed ID: 15164527 [No Abstract] [Full Text] [Related]
15. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study. Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999 [TBL] [Abstract][Full Text] [Related]
16. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095 [TBL] [Abstract][Full Text] [Related]
17. Palliative treatment in advanced hepatocellular carcinoma: has it made any difference? Paul SB; Manjunatha YC; Acharya SK Trop Gastroenterol; 2009; 30(3):125-34. PubMed ID: 20306740 [TBL] [Abstract][Full Text] [Related]
18. Novel advancements in the management of hepatocellular carcinoma in 2008. Llovet JM; Bruix J J Hepatol; 2008; 48 Suppl 1():S20-37. PubMed ID: 18304676 [TBL] [Abstract][Full Text] [Related]
19. [The treatment of hepatocellular carcinoma. New developments]. Kuiken SD; van Delden OM; Richel DJ; Jansen PL Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326 [No Abstract] [Full Text] [Related]
20. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes? Di Bisceglie AM Liver Transpl; 2005 Nov; (11 Suppl 2):S10-3. PubMed ID: 16237728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]